- Chembio Diagnostics (CEMI +1.3%) announces that its SURE CHECK HIV 1/2 self-testing device has been launched in the UK and France under private label. In the UK, BioSure Ltd. will market the product as BioSURE HIV Self Test while in France, AAZ will market it as autotest VIH.
- People living with HIV infection in the UK and France total 110K and 160K, respectively. The number of people unaware of their positive HIV status is about 26K and 29K, respectively, in the UK and France.
- SURE CHECK HIV 1/2 is marketing in the U.S. as Clearview Complete.